Q-tracks

A College of American Pathologists program of continuous laboratory monitoring and longitudinal performance tracking

Richard J. Zarbo, Bruce A. Jones, Richard C. Friedberg, Paul N. Valenstein, Stephen W. Renner, Ronald B Schifman, Molly K. Walsh, Peter J. Howanitz

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Context. - Continuous monitoring of key laboratory indicators of quality by hundreds of laboratories in a standardized measurement program affords an opportunity to document the influence of longitudinal tracking on performance improvement by participants focused on that outcome. Objective. - To describe the results of the first 2 years of participation in a unique continuous performance assessment program for pathology and laboratory medicine. Design. - Participants in any of 6 modules in the 1999 and 2000 College of American Pathologists (CAP) Q-Tracks program collected data according to defined methods and sampling intervals on standardized input forms. Data were submitted quarterly to CAP for statistical analysis. Interinstitutional comparison reports returned in 6 weeks provided each laboratory with its performance profile of key indicators and its percentile ranking compared with all participants in that quarter. This also included longitudinal comparisons of performance during previous cumulative quarters. Control charts graphically displayed data with flags identifying performance points that were out of statistical control. Setting. - Hospital-based laboratories in the United States (98%), Canada, and Australia. Participants. - Voluntary subscriber laboratories in the CAP Q-Tracks performance measurement program: roughly 70% from hospitals of 300 occupied beds or fewer, 65% from private, nonprofit institutions, slightly more than half located in cities, one third from teaching hospitals, and 20% with pathology residency training programs. Main Outcome Measures. - Each module measured several major and additional minor quality indicators and unbenchmarked individualized data for internal use. Results. - Participants in 4 of 6 Q-Tracks continuous monitors demonstrated statistically significant performance improvement trends in 1999 and 2000, which were most marked for laboratories that continued participation throughout both years. These monitors were wristband patient identification, laboratory specimen acceptability, blood product wastage, and intraoperative frozen section consultation. Conclusions. - Key continuous indicators chosen on the basis of a decade's experience in the CAP Q-Probes quality improvement program are useful measurement and benchmarking tools for laboratories to improve performance. In general, measures in which there is a broad range of demonstrable performance initially are most optimal for subsequent improvement using continuous monitoring. These studies have shown that quality is not static, but rather is a moving benchmark of performance as seen in the redefinition of benchmarks over time by participants in the first 2 years of the CAP Q-Tracks program.

Original languageEnglish (US)
Pages (from-to)1036-1044
Number of pages9
JournalArchives of Pathology and Laboratory Medicine
Volume126
Issue number9
StatePublished - Sep 2002
Externally publishedYes

Fingerprint

Benchmarking
Pathology
Hospital Laboratories
Pathologists
Frozen Sections
Internship and Residency
Quality Improvement
Teaching Hospitals
Canada
Referral and Consultation
Medicine
Outcome Assessment (Health Care)
Education

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Zarbo, R. J., Jones, B. A., Friedberg, R. C., Valenstein, P. N., Renner, S. W., Schifman, R. B., ... Howanitz, P. J. (2002). Q-tracks: A College of American Pathologists program of continuous laboratory monitoring and longitudinal performance tracking. Archives of Pathology and Laboratory Medicine, 126(9), 1036-1044.

Q-tracks : A College of American Pathologists program of continuous laboratory monitoring and longitudinal performance tracking. / Zarbo, Richard J.; Jones, Bruce A.; Friedberg, Richard C.; Valenstein, Paul N.; Renner, Stephen W.; Schifman, Ronald B; Walsh, Molly K.; Howanitz, Peter J.

In: Archives of Pathology and Laboratory Medicine, Vol. 126, No. 9, 09.2002, p. 1036-1044.

Research output: Contribution to journalArticle

Zarbo, RJ, Jones, BA, Friedberg, RC, Valenstein, PN, Renner, SW, Schifman, RB, Walsh, MK & Howanitz, PJ 2002, 'Q-tracks: A College of American Pathologists program of continuous laboratory monitoring and longitudinal performance tracking', Archives of Pathology and Laboratory Medicine, vol. 126, no. 9, pp. 1036-1044.
Zarbo, Richard J. ; Jones, Bruce A. ; Friedberg, Richard C. ; Valenstein, Paul N. ; Renner, Stephen W. ; Schifman, Ronald B ; Walsh, Molly K. ; Howanitz, Peter J. / Q-tracks : A College of American Pathologists program of continuous laboratory monitoring and longitudinal performance tracking. In: Archives of Pathology and Laboratory Medicine. 2002 ; Vol. 126, No. 9. pp. 1036-1044.
@article{928f70d9f4cc4908ae48840aa40074e9,
title = "Q-tracks: A College of American Pathologists program of continuous laboratory monitoring and longitudinal performance tracking",
abstract = "Context. - Continuous monitoring of key laboratory indicators of quality by hundreds of laboratories in a standardized measurement program affords an opportunity to document the influence of longitudinal tracking on performance improvement by participants focused on that outcome. Objective. - To describe the results of the first 2 years of participation in a unique continuous performance assessment program for pathology and laboratory medicine. Design. - Participants in any of 6 modules in the 1999 and 2000 College of American Pathologists (CAP) Q-Tracks program collected data according to defined methods and sampling intervals on standardized input forms. Data were submitted quarterly to CAP for statistical analysis. Interinstitutional comparison reports returned in 6 weeks provided each laboratory with its performance profile of key indicators and its percentile ranking compared with all participants in that quarter. This also included longitudinal comparisons of performance during previous cumulative quarters. Control charts graphically displayed data with flags identifying performance points that were out of statistical control. Setting. - Hospital-based laboratories in the United States (98{\%}), Canada, and Australia. Participants. - Voluntary subscriber laboratories in the CAP Q-Tracks performance measurement program: roughly 70{\%} from hospitals of 300 occupied beds or fewer, 65{\%} from private, nonprofit institutions, slightly more than half located in cities, one third from teaching hospitals, and 20{\%} with pathology residency training programs. Main Outcome Measures. - Each module measured several major and additional minor quality indicators and unbenchmarked individualized data for internal use. Results. - Participants in 4 of 6 Q-Tracks continuous monitors demonstrated statistically significant performance improvement trends in 1999 and 2000, which were most marked for laboratories that continued participation throughout both years. These monitors were wristband patient identification, laboratory specimen acceptability, blood product wastage, and intraoperative frozen section consultation. Conclusions. - Key continuous indicators chosen on the basis of a decade's experience in the CAP Q-Probes quality improvement program are useful measurement and benchmarking tools for laboratories to improve performance. In general, measures in which there is a broad range of demonstrable performance initially are most optimal for subsequent improvement using continuous monitoring. These studies have shown that quality is not static, but rather is a moving benchmark of performance as seen in the redefinition of benchmarks over time by participants in the first 2 years of the CAP Q-Tracks program.",
author = "Zarbo, {Richard J.} and Jones, {Bruce A.} and Friedberg, {Richard C.} and Valenstein, {Paul N.} and Renner, {Stephen W.} and Schifman, {Ronald B} and Walsh, {Molly K.} and Howanitz, {Peter J.}",
year = "2002",
month = "9",
language = "English (US)",
volume = "126",
pages = "1036--1044",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "9",

}

TY - JOUR

T1 - Q-tracks

T2 - A College of American Pathologists program of continuous laboratory monitoring and longitudinal performance tracking

AU - Zarbo, Richard J.

AU - Jones, Bruce A.

AU - Friedberg, Richard C.

AU - Valenstein, Paul N.

AU - Renner, Stephen W.

AU - Schifman, Ronald B

AU - Walsh, Molly K.

AU - Howanitz, Peter J.

PY - 2002/9

Y1 - 2002/9

N2 - Context. - Continuous monitoring of key laboratory indicators of quality by hundreds of laboratories in a standardized measurement program affords an opportunity to document the influence of longitudinal tracking on performance improvement by participants focused on that outcome. Objective. - To describe the results of the first 2 years of participation in a unique continuous performance assessment program for pathology and laboratory medicine. Design. - Participants in any of 6 modules in the 1999 and 2000 College of American Pathologists (CAP) Q-Tracks program collected data according to defined methods and sampling intervals on standardized input forms. Data were submitted quarterly to CAP for statistical analysis. Interinstitutional comparison reports returned in 6 weeks provided each laboratory with its performance profile of key indicators and its percentile ranking compared with all participants in that quarter. This also included longitudinal comparisons of performance during previous cumulative quarters. Control charts graphically displayed data with flags identifying performance points that were out of statistical control. Setting. - Hospital-based laboratories in the United States (98%), Canada, and Australia. Participants. - Voluntary subscriber laboratories in the CAP Q-Tracks performance measurement program: roughly 70% from hospitals of 300 occupied beds or fewer, 65% from private, nonprofit institutions, slightly more than half located in cities, one third from teaching hospitals, and 20% with pathology residency training programs. Main Outcome Measures. - Each module measured several major and additional minor quality indicators and unbenchmarked individualized data for internal use. Results. - Participants in 4 of 6 Q-Tracks continuous monitors demonstrated statistically significant performance improvement trends in 1999 and 2000, which were most marked for laboratories that continued participation throughout both years. These monitors were wristband patient identification, laboratory specimen acceptability, blood product wastage, and intraoperative frozen section consultation. Conclusions. - Key continuous indicators chosen on the basis of a decade's experience in the CAP Q-Probes quality improvement program are useful measurement and benchmarking tools for laboratories to improve performance. In general, measures in which there is a broad range of demonstrable performance initially are most optimal for subsequent improvement using continuous monitoring. These studies have shown that quality is not static, but rather is a moving benchmark of performance as seen in the redefinition of benchmarks over time by participants in the first 2 years of the CAP Q-Tracks program.

AB - Context. - Continuous monitoring of key laboratory indicators of quality by hundreds of laboratories in a standardized measurement program affords an opportunity to document the influence of longitudinal tracking on performance improvement by participants focused on that outcome. Objective. - To describe the results of the first 2 years of participation in a unique continuous performance assessment program for pathology and laboratory medicine. Design. - Participants in any of 6 modules in the 1999 and 2000 College of American Pathologists (CAP) Q-Tracks program collected data according to defined methods and sampling intervals on standardized input forms. Data were submitted quarterly to CAP for statistical analysis. Interinstitutional comparison reports returned in 6 weeks provided each laboratory with its performance profile of key indicators and its percentile ranking compared with all participants in that quarter. This also included longitudinal comparisons of performance during previous cumulative quarters. Control charts graphically displayed data with flags identifying performance points that were out of statistical control. Setting. - Hospital-based laboratories in the United States (98%), Canada, and Australia. Participants. - Voluntary subscriber laboratories in the CAP Q-Tracks performance measurement program: roughly 70% from hospitals of 300 occupied beds or fewer, 65% from private, nonprofit institutions, slightly more than half located in cities, one third from teaching hospitals, and 20% with pathology residency training programs. Main Outcome Measures. - Each module measured several major and additional minor quality indicators and unbenchmarked individualized data for internal use. Results. - Participants in 4 of 6 Q-Tracks continuous monitors demonstrated statistically significant performance improvement trends in 1999 and 2000, which were most marked for laboratories that continued participation throughout both years. These monitors were wristband patient identification, laboratory specimen acceptability, blood product wastage, and intraoperative frozen section consultation. Conclusions. - Key continuous indicators chosen on the basis of a decade's experience in the CAP Q-Probes quality improvement program are useful measurement and benchmarking tools for laboratories to improve performance. In general, measures in which there is a broad range of demonstrable performance initially are most optimal for subsequent improvement using continuous monitoring. These studies have shown that quality is not static, but rather is a moving benchmark of performance as seen in the redefinition of benchmarks over time by participants in the first 2 years of the CAP Q-Tracks program.

UR - http://www.scopus.com/inward/record.url?scp=0036770449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036770449&partnerID=8YFLogxK

M3 - Article

VL - 126

SP - 1036

EP - 1044

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 9

ER -